Results
Dr Lal PathLabs Q1 Net Profit Rises 28% to ₹1.7B
Approved unaudited standalone and consolidated financial results for Q1 FY27, showing revenue growth of 19% YoY to ₹7.98B.
Declared interim dividend of ₹5 per share (50% on face value ₹10) with record
